Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Surrozen logo — Surrozen is a biotechnology company focused on discovering a...

Surrozen

Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway

Founded 2016 United States South San Francisco, United States 67 employees Total: $445.50M Biotechnology, Health Care +1

General Information

Company Name Surrozen
Founded Year 2016
Location United States South San Francisco, United States
Founders / Decision Makers
Team member
Employees 67
Industries Biotechnology, Health Care, Pharmaceutical
Business Model B2B
Revenue Model Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Surrozen. To contact Surrozen, visit surrozen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Surrozen compare?

A PDF of Surrozen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Surrozen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Surrozen

Surrozen is a biotechnology company specializing in the discovery and development of innovative regenerative medicines. The company aims to harness the self-renewal properties of the body by precisely controlling the Wnt signaling pathway.

Founded in 2016 by a team of five trailblazing scientists, including K. Christopher Garcia, Ph.D., Roel Nusse, Ph.D. and others, Surrozen draws expertise from institutions like Stanford University and the Princess Maxima Center. The company's pioneering work is backed by the renowned venture capital firm, The Column Group.

The company recently secured a substantial $175.00 million through a Private Placement on 01 March 2025, with support from major investors such as RA Capital Management, Venrock, and 5AM Ventures among others. This investment fortifies Surrozen's position at the forefront of Biotechnology, Health Care, and Pharmaceutical industries.

Business keywords: Regenerative Medicine, Wnt Signaling Pathway, Tissue-Specific Antibodies, Drug Discovery, Therapeutic Development, Self-Renewal Properties, Tissue Repair, Liver Failure, Disease Modulation, Biological Repair Mechanisms, Intestinal Diseases, Liver Diseases, CNS Disorders, Venture Capital Backed

Services & Products

Development of Multi-target Antibody Therapeutics
Modulation of Wnt Signaling Pathway

Target Customers

Patients with Ophthalmic Diseases Healthcare Providers Biotechnology and Pharmaceutical Companies

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Private Placement VC $175.00M 12
RA Capital Management Venrock 5AM Ventures
RA Capital Management, Venrock +10
01 Mar 2025
Private Placement VC $17.50M 2
RA Capital Management The Column Group
RA Capital Management, The Column Group
01 Apr 2024
Spac IPO $120.00M 2
The Column Group Consonance Capital
The Column Group, Consonance Capital
01 Apr 2021
Series C $50.00M 2
Horizons Ventures The Column Group
Horizons Ventures, The Column Group
01 Jun 2020
Series B $50.00M 2
Horizons Ventures The Column Group
Horizons Ventures, The Column Group
01 Mar 2019
Series A $33.00M 1
The Column Group
The Column Group
01 Feb 2017
Spinout Undisclosed 1
Stanford University
01 Mar 2016

Surrozen Alternatives & Competitors

View All Alternatives
Surrozen vs
Biosplice Therapeutics
Biosplice Therapeutics United States

Restore health by delivering first-in-class therapies that harness alternative splicing

Grant
37 employees
Biotechnology, Health Care
Compare Surrozen vs Biosplice Therapeutics
Surrozen vs
CK Regeon
CK Regeon Korea South

CK Regeon Inc. is a biotechnology-based company aiming to develop First-In-Class drugs with clear MO...

Series B
9 employees
Biotechnology, Health Care
Compare Surrozen vs CK Regeon
Surrozen vs
Navitor Pharmaceuticals
Navitor Pharmaceuticals United States

Navitor Pharmaceuticals, Inc., is a biopharmaceutical company developing novel medicines by targetin...

Venture round
10 employees
Biopharma, Biotechnology
Also compare with: Surrozen vs HemoShear Therapeutics HemoShear Therapeutics View all alternatives

FAQ About Surrozen

Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway
Surrozen was founded in 2016.
Surrozen is headquartered in South San Francisco, United States.
Surrozen operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Regenerative Medicine, Wnt Signaling Pathway, Tissue-Specific Antibodies and Drug Discovery. Its customers include Patients with Ophthalmic Diseases, Healthcare Providers and Biotechnology and Pharmaceutical Companies.
Surrozen has a B2B business model. Its revenue comes from Product Sales and Licensing.
Surrozen has approximately 67 employees.
Surrozen has completed 7 funding rounds, raising a total of $445.50M.
Surrozen offers: Development of Multi-target Antibody Therapeutics, Modulation of Wnt Signaling Pathway.
Top alternatives and competitors to Surrozen include Biosplice Therapeutics, CK Regeon, Navitor Pharmaceuticals, HemoShear Therapeutics, ReNeuron Group Plc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Surrozen and Biosplice Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Surrozen, https://bouncewatch.com/company/surrozen, updated 22 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes